EXPAREL or Lidocane as Local Anesthetic in Patients Undergoing Pleuroscopy With Pleural Biopsy and Indwelling Pleural Catheter Placement
Running, not enrolling · Phase 2
Conditions studied: Malignant Pleural Neoplasm
In brief
This phase II trial investigates the effect of EXPAREL compared to lidocane as a local anesthetic in patients who are undergoing pleuroscopy with pleural biopsy and indwelling pleural catheter placement. This trial aims to see whether EXPAREL or lidocane is able to make patients more comfortable.
Key facts
- Study ID
- NCT05044468
- Run by
- M.D. Anderson Cancer Center
- People needed
- 80
- Starts
- 2021-03-23
- Expected to finish
- 2026-05-31
- Last updated by the study team
- 2026-03-09
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Referral to pulmonary services for pleuroscopy with biopsies and IPC placement/chest tube placement
- Age > 18
You may not qualify if…
- Inability to provide informed consent
- Study subject has any disease or condition that interferes with safe completion of the study including:
- a. Allergic reaction to EXPAREL
- Need for pleurodesis
- Allergies to lidocaine or other local anesthetics.
- Pregnancy
- Advanced liver disease where the clinician deems the procedure unsafe
Where it is running
- M D Anderson Cancer Center — Houston, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.